ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Pain Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

5,674Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 13

$448K Total Retail Price of All Prescriptions

Rank: 4 out of 13

495 Patients Receiving at Least One Drug in Part D
56%Patients 65 Years and Older
51% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

40% of this provider’s 495 patients filled at least one prescription for a schedule two drug, compared to an average of 42%.

Schedule Three
Controlled Substances

45% of this provider’s 495 patients filled at least one prescription for a schedule three drug, compared to an average of 50%.

Risky Drugs to Seniors

5% of this provider’s 2,720 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 4%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 17%.

Prescription Price

$79 was the average price of a prescription from this provider, compared to $89 among peers.

Prescriptions per Patient

11 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
HYDROCODONE-ACETAMINOPHEN 1,226 583 S3 1 1
GABAPENTIN 530 296 2 2
OXYCODONE HCL-ACETAMINOPHEN 368 185 S2 3 6
MORPHINE SULFATE ER 234 48 S2 4 4
ENDOCET 203 73 S2 5 13
FENTANYL 196 135 S2 6 11
CYMBALTA 178 115 7 14
TRAMADOL HCL 154 98 8 9
BACLOFEN 147 43 9 20
LYRICA 115 69 10 12
MELOXICAM 113 36 11 17
METHOCARBAMOL 108 37 R 12 19
ZOLPIDEM TARTRATE 105 39 13 7
TIZANIDINE HCL 102 20 14 5
OXYCODONE HCL 90 49 S2 15 3
CELEBREX 87 57 16 27
AMITRIPTYLINE HCL 79 47 R 17 29
OXYCONTIN 76 26 S2 18 8
LIDODERM 71 49 19 36
CYCLOBENZAPRINE HCL 68 12 R 20 15
NORTRIPTYLINE HCL 67 0 21 38
HYDROMORPHONE HCL 63 39 S2 22 23
NABUMETONE 63 21 22 39
TRAZODONE HCL 63 40 22 22
NEXIUM 61 30 25 28
VOLTAREN 51 35 26 43
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 28, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.